Performance of p16INK4a-cytology, HPV mRNA, and HPV DNA testing to identify high grade cervical dysplasia in women with abnormal screening results

Gynecologic Oncology

Volumn 119, Issue 1, 2010, Pages 98-105

  Reuschenbach, Miriam ^a   Clad, Andreas ^b   Von Knebel Doeberitz, Christina ^a   Wentzensen, Nicolas ^a   Rahmsdorf, Janina ^b   Schaffrath, Frauke ^b   Griesser, Henrik ^c   Freudenberg, Nikolaus ^b   Von Knebel Doeberitz, Magnus ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c Center of Pathology and Cytodiagnostics   (Germany)

Author keywords

Cervical cancer; Cervical intraepithelial neoplasia; HPV DNA; HPV mRNA; p16 INK4a; Screening

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; DNA; EOSIN; HEMATOXYLIN; MESSENGER RNA; ONCOPROTEIN; VIRUS DNA;

ADULT; ARTICLE; CANCER GRADING; CANCER SCREENING; CLINICAL TRIAL; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NONHUMAN; OUTCOME ASSESSMENT; PREDICTION AND FORECASTING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SINGLE BLIND PROCEDURE; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DYSPLASIA; VIRUS INFECTION; WART VIRUS; BIOSYNTHESIS; GENETICS; METABOLISM; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; PATHOLOGY; VIROLOGY;

ADULT; CROSS-SECTIONAL STUDIES; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, VIRAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL DYSPLASIA;

EID: 77956650797     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.06.011     Document Type: Article

References (31)

1. S.A. Cannistra, and J.M. Niloff Cancer of the uterine cervix N Engl J Med 334 1996 1030 1038
2. M.H. Stoler, and M. Schiffman Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study JAMA 285 2001 1500 1505
3. ALTS Group A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations Am J Obstet Gynecol 188 2003 1393 1400
4. H. zur Hausen Human papillomaviruses and their possible role in squamous cell carcinomas Curr Top Microbiol Immunol 78 1977 1 30
5. M. Schiffman, P.E. Castle, J. Jeronimo, A.C. Rodriguez, and S. Wacholder Human papillomavirus and cervical cancer Lancet 370 2007 890 907
6. H. zur Hausen Immortalization of human cells and their malignant conversion by high risk human papillomavirus genotypes Semin Cancer Biol 9 1999 405 411
7. M. von Knebel Doeberitz, and S. Vinokurova Host factors in HPV-related carcinogenesis: cellular mechanisms controlling HPV infections Arch Med Res 40 6 2009 435 442
8. M.H. Mayrand, E. Duarte-Franco, I. Rodrigues, S.D. Walter, J. Hanley, and A. Ferenczy Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer N Engl J Med 357 2007 1579 1588
9. P. Naucler, W. Ryd, S. Tornberg, A. Strand, G. Wadell, and K. Elfgren Human papillomavirus and Papanicolaou tests to screen for cervical cancer N Engl J Med 357 2007 1589 1597
10. N.W. Bulkmans, J. Berkhof, L. Rozendaal, F.J. van Kemenade, A.J. Boeke, and S. Bulk Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial Lancet 370 2007 1764 1772
11. C.J. Meijer, J. Berkhof, P.E. Castle, A.T. Hesselink, E.L. Franco, and G. Ronco Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older Int J Cancer 124 2009 516 520
12. F. Carozzi, M. Confortini, P.P. Dalla, A. Del Mistro, A. Gillio-Tos, and L. De Marco Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial Lancet Oncol 9 2008 937 945
13. N. Wentzensen, and M. von Knebel Doeberitz Biomarkers in cervical cancer screening Dis Markers 23 2007 315 330
14. M. von Knebel Doeberitz New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections Eur J Cancer 38 2002 2229 2242
15. K. Cuschieri, and N. Wentzensen Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia Cancer Epidemiol Biomarkers Prev 17 2008 2536 2545
16. T. Sano, T. Oyama, K. Kashiwabara, T. Fukuda, and T. Nakajima Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions Am J Pathol 153 1998 1741 1748
17. M. von Knebel Doeberitz New molecular tools for efficient screening of cervical cancer Dis Markers 17 2001 123 199
18. R. Klaes, A. Benner, T. Friedrich, R. Ridder, S. Herrington, and D. Jenkins p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia Am J Surg Pathol 26 2002 1389
19. L.C. Horn, A. Reichert, A. Oster, S.F. Arndal, M.J. Trunk, and R. Ridder Immunostaining for p16INK4a used as a conjunctive tool improves interobserver agreement of the histologic diagnosis of cervical intraepithelial neoplasia Am J Surg Pathol 32 2008 502 512
20. N. Wentzensen, C. Bergeron, F. Cas, S. Vinokurova, and M. von Knebel Doeberitz Triage of women with ASCUS and LSIL cytology: use of qualitative assessment of p16INK4a positive cells to identify patients with high-grade cervical intraepithelial neoplasia Cancer 111 2007 58 66
21. A. Szarewski, L. Ambroisine, L. Cadman, J. Austin, L. Ho, and G. Terry Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears Cancer Epidemiol Biomarkers Prev 17 2008 3033 3042
22. P.E. Castle, J. Dockter, C. Giachetti, F.A. Garcia, M.K. McCormick, and A.L. Mitchell A cross-sectional study of a prototype carcinogenic human papillomavirus E6/E7 messenger RNA assay for detection of cervical precancer and cancer Clin Cancer Res 13 2007 2599 2605
23. J. Dockter, A. Schroder, C. Hill, L. Guzenski, J. Monsonego, and C. Giachetti Clinical performance of the APTIMA HPV assay for the detection of high-risk HPV and high-grade cervical lesions J Clin Virol 45 Suppl 1 2009 S55 S61
24. M. Arbyn, G. Ronco, J. Cuzick, N. Wentzensen, and P.E. Castle How to evaluate emerging technologies in cervical cancer screening? Int J Cancer 125 2009 2489 2496
25. P.E. Castle, M. Schiffman, C.M. Wheeler, and D. Solomon Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2 Obstet Gynecol 113 2009 18 25
26. Q. Zhang, L. Kuhn, L.A. Denny, M. De Souza, S. Taylor, and T.C. Wright Jr. Impact of utilizing p16INK4A immunohistochemistry on estimated performance of three cervical cancer screening tests Int J Cancer 120 2007 351 356
27. N. Wentzensen, C. Bergeron, F. Cas, D. Eschenbach, S. Vinokurova, and M. von Knebel Doeberitz Evaluation of a nuclear score for p16INK4a-stained cervical squamous cells in liquid-based cytology samples Cancer 105 2005 461 467
28. J.L. Meyer, D.W. Hanlon, B.T. Andersen, O.F. Rasmussen, and K. Bisgaard Evaluation of p16INK4a expression in ThinPrep cervical specimens with the CINtec p16INK4a assay: correlation with biopsy follow-up results Cancer 111 2007 83 92
29. R.G. Pretorius, Y.P. Bao, J.L. Belinson, R.J. Burchette, J.S. Smith, and Y.L. Qiao Inappropriate gold standard bias in cervical cancer screening studies Int J Cancer 121 2007 2218 2224
30. C. Bergeron, J. Ordi, D. Schmidt, M.J. Trunk, T. Keller, and R. Ridder Conjunctive p16INK4a testing significantly increases accuracy in diagnosing high-grade cervical intraepithelial neoplasia Am J Clin Pathol 133 2010 395 406
31. N. Wentzensen, R.E. Zuna, M.E. Sherman, M.A. Gold, M. Schiffman, and S.T. Dunn Accuracy of cervical specimens obtained for biomarker studies in women with CIN3 Gynecol Oncol 115 2009 493 496